1. Volume 154, Issue 4, Pages 874-885 (March 2018)
Factors Associated With Response to Teduglutide in Patients With Short-Bowel Syndrome and Intestinal Failure 
Palle B. Jeppesen, Simon M. Gabe, Douglas L. Seidner, Hak-Myung Lee, Clément Olivier 
Gastroenterology 
Volume 154, Issue 4, Pages (March 2018)
DOI: /j.gastro
Copyright © 2018 AGA Institute Terms and Conditions

2. Figure 1
Absolute PS volume reduction at week 24 vs baseline PS volume in patients treated with teduglutide (A) or placebo (B). + symbol represents patients who became PS independent by the end of the 2-year, open-label extension of this phase III study (NCT ; EudraCT 2009–011679–65).
Gastroenterology  , DOI: ( /j.gastro )
Copyright © 2018 AGA Institute Terms and Conditions

3. Figure 2
Absolute change in oral fluid intake (A, B), urine volume (C, D), and fluid composite effect (E, F) at week 24 vs baseline PS volume in patients treated with teduglutide (A, C, E) or placebo (B, D, F). + symbol represents patients who became PS independent by the end of the 2-year, open-label extension of this phase III study (NCT ; EudraCT ).
Gastroenterology  , DOI: ( /j.gastro )
Copyright © 2018 AGA Institute Terms and Conditions